Cyprotex
Alex Williams is a skilled Senior Scientist at Cyprotex, with a career spanning from March 2017 to the present, specializing in high and low throughput compound screening and diverse assay techniques including LCMS/MS and fluorescence. Prior experience includes serving as Store Manager at Wine Rack, where customer engagement and product knowledge were essential, and a brief tenure at MedImmune, focusing on Alzheimer's and prion-like diseases through various laboratory techniques. Additionally, experience at The University of Manchester involved stroke research methodologies. Alex holds a Bachelor’s Degree in Neuroscience from the University of Leeds, earned between 2013 and 2016.
This person is not in any offices
Cyprotex
Founded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and USA, was acquired by Evotec (www.evotec.com) in 2016. The Evotec Group offer expert support from early discovery through to clinical development. * High-throughput ADME screening * Customised ADME assays * In silico ADME predictive modeling * In vitro toxicology